Denmark-based Coloplast a/s has agreed to pay about $16 million to settle about 400 cases involving its transvaginal mesh implants, according to a report on Bloomberg. In a move that may establish a ...

We think Coloplast's urology segment could offer growth potential and cross-selling opportunities. Thus far, the firm has been more successful in the United States with its slings, kidney stone ...